Skip to main content
. 2017 Sep 25;38(5):2735–2740. doi: 10.3892/or.2017.5994

Table II.

Relationship between the expression of miR-146a and miR-146b and different clinical features of PTC patients.

Item n miR-146a expression P-value miR-146b expression P-value
Age (years) 0.0692 0.0782
  ≤50 37 5.98±1.33 3.53±1.08
  <50 36 6.16±1.28 3.85±1.12
GA125 (U/ml) 0.0619 0.0873
  ≤35 43 5.87±1.08 5.63±1.62
  >35 30 6.16±1.22 5.57±1.29
FIGO staging 0.0538 0.0686
  Stage I–II 28 6.29±1.39 6.08±1.19
  Stage III–IV 45 6.89±1.87 5.95±2.01
Lymphatic metastasis 0.0078 0.0097
  Yes 36 6.76±2.01 6.73±1.78
  No 37 3.58±1.96 2.17±1.05
Recurrence 0.0086 0.0176
  Yes 17 5.97±1.86 5.32±1.25
  No 56 2.38±1.29 3.17±1.03